Label Changes for:
Coly-Mycin M Parenteral Solution (colistimethate sodium, USP)
Changes have been made to the WARNINGS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- Maximum daily dose calculated from colistin base activity should not exceed 5 mg/kg/day with normal renal function.